IL-27 enhances Leishmania amazonensis infection via ds-RNA dependent kinase (PKR) and IL-10 signaling

Immunobiology

Volumn 220, Issue 4, 2015, Pages 437-444

  Barreto de Souza, Victor ^a   Ferreira, Pedro L C ^a   de Carvalho Vivarini, Aislan ^b   Calegari Silva, Teresa ^b   Soares, Deivid Costa ^b   Regis, Eduardo G ^a   Pereira, Renata M S ^b   Silva, Aristóbolo M ^c   Saraiva, Elvira M ^b   Lopes, Ulisses G ^b,d   Bou Habib, Dumith Chequer ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY   (Brazil)

Author keywords

IL 10; IL 27; Leishmania; Macrophages; PKR

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 27; PROTEIN KINASE R; TOLL LIKE RECEPTOR 2; INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FOOT PAD; GENE DELETION; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; LEISHMANIA; LEISHMANIA AMAZONENSIS INFECTION; LEISHMANIASIS; LYMPH NODE; MALE; MOUSE; NONHUMAN; PARASITE DEVELOPMENT; PARASITE LOAD; PERITONEUM MACROPHAGE; PKR GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; LEISHMANIA MEXICANA; MACROPHAGE; METABOLISM; PARASITOLOGY; SKIN LEISHMANIASIS;

ANIMALS; CELL LINE; EIF-2 KINASE; HUMANS; INTERFERON TYPE I; INTERLEUKIN-10; INTERLEUKIN-27; LEISHMANIA MEXICANA; LEISHMANIASIS, CUTANEOUS; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2;

EID: 84924972994     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2014.11.006     Document Type: Article

References (41)

1. Ansari N.A., Kumar R., Gautam S., Nylen S., Singh O.P., Sundar S., Sacks D. IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis. J. Immunol. 2011, 186:3977.
2. Artis D., Johnson L.M., Joyce K., Saris C., Villarino A., Hunter C.A., Scott P. Cutting edge: early IL-4 production governs the requirement for IL-27-WSX-1 signaling in the development of protective Th1 cytokine responses following Leishmania major infection. J. Immunol. 2004, 172:4672.
3. Bancroft A.J., Humphreys N.E., Worthington J.J., Yoshida H., Grencis R.K. WSX-1: a key role in induction of chronic intestinal nematode infection. J. Immunol. 2004, 172:7635.
4. Barreto-de-Souza V., Pacheco G.J., Silva A.R., Castro-Faria-Neto H.C., Bozza P.T., Saraiva E.M., Bou-Habib D.C. Increased Leishmania replication in HIV-1-infected macrophages is mediated by tat protein through cyclooxygenase-2 expression and prostaglandin E2 synthesis. J. Infect. Dis. 2006, 194:846.
5. Batten M., Kljavin N.M., Li J., Walter M.J., de Sauvage F.J., Ghilardi N. Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells. J. Immunol. 2008, 180:2752.
6. Bogdan C., Mattner J., Schleicher U. The role of type I interferons in non-viral infections. Immunol. Rev. 2004, 202:33.
7. Cummings H.E., Tuladhar R., Satoskar A.R. Cytokines and their STATs in cutaneous and visceral leishmaniasis. J. Biomed. Biotechnol. 2010, 2010:294389.
8. Freitas do Rosário A.P., Lamb T., Spence P., Stephens R., Lang A., Roers A., Muller W., O'Garra A., Langhorne J. IL-27 promotes IL-10 production by effector Th1 CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infection. J Immunol. 2012, 188:1178.
9. Greenwell-Wild T., Vazquez N., Jin W., Rangel Z., Munson P.J., Wahl S.M. Interleukin-27 inhibition of HIV-1 involves an intermediate induction of type I interferon. Blood 2009, 114:1864.
10. Hause L., Al-Salleeh F.M., Petro T.M. Expression of IL-27 p28 by Theiler's virus-infected macrophages depends on TLR3 and TLR7 activation of JNK-MAP-kinases. Antiviral Res. 2007, 76:159.
11. Hunter C.A., Villarino A., Artis D., Scott P. The role of IL-27 in the development of T-cell responses during parasitic infections. Immunol. Rev. 2004, 202:106.
12. Imamichi T., Yang J., Huang D., Brann W., Fullmer T.W., Adelsberger B.A., Lempicki J.W., Baseler R.A., Lane M.W.H.C. IL-27, a novel anti-HIV cytokine, activates multiple interferon-inducible genes in macrophages. AIDS 2008, 22:39.
13. Imamichi T., Yang J., Huang D.W., Sherman B., Lempicki R.A. Interleukin-27 induces interferon-inducible genes: analysis of gene expression profiles using Affymetrix microarray and DAVID. Methods Mol. Biol. 2012, 820:25.
14. Iyer S.S., Ghaffari A.A., Cheng G. Lipopolysaccharide-mediated IL-10 transcriptional regulation requires sequential induction of type I IFNs and IL-27 in macrophages. J. Immunol. 2010, 185:6599.
15. Jankowski M., Kopinski P., Goc A. Interleukin-27: biological properties and clinical application. Arch. Immunol. Ther. Exp. (Warsz) 2010, 58:417.
16. Kaye P., Scott P. Leishmaniasis: complexity at the host-pathogen interface. Nat. Rev. Microbiol. 2011, 9:604.
17. Khouri R., Bafica A., Silva Mda P., Noronha A., Kolb J.P., Wietzerbin J., Barral A., Barral-Netto M., Van Weyenbergh J. IFN-beta impairs superoxide-dependent parasite killing in human macrophages: evidence for a deleterious role of SOD1 in cutaneous leishmaniasis. J. Immunol. 2009, 182:2525.
18. Kim H.S., Go H., Akira S., Chung D.H. TLR2-mediated production of IL-27 and chemokines by respiratory epithelial cells promotes bleomycin-induced pulmonary fibrosis in mice. J. Immunol. 2011, 187:4007.
19. Kurtzhals J.A., Hey A.S., Jardim A., Kemp M., Schaefer K.U., Odera E.O., Christensen C.B., Githure J.I., Olafson R.W., Theander T.G., et al. Dichotomy of the human T cell response to Leishmania antigens. II. Absent or Th2-like response to gp63 and Th1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients. Clin. Exp. Immunol. 1994, 96:416.
20. Lima H.C., Bleyenberg J.A., Titus R.G. A simple method for quantifying Leishmania in tissues of infected animals. Parasitol. Today 1997, 13:80.
21. Liu L., Cao Z., Chen J., Li R., Cao Y., Zhu C., Wu K., Wu J., Liu F., Zhu Y. Influenza A virus induces interleukin-27 through cyclooxygenase-2 and protein kinase A signaling. J. Biol. Chem. 2012, 287:11899.
22. Locksley R.M., Heinzel F.P., Sadick M.D., Holaday B.J., Gardner K.D. Murine cutaneous leishmaniasis: susceptibility correlates with differential expansion of helper T-cell subsets. Ann. Inst. Pasteur Immunol. 1987, 138:744.
23. Maroof A., Kaye P.M. Temporal regulation of interleukin-12p70 (IL-12p70) and IL-12-related cytokines in splenic dendritic cell subsets during Leishmania donovani infection. Infect. Immun. 2008, 76:239.
24. Meurs E., Chong K., Galabru J., Thomas N.S., Kerr I.M., Williams B.R., Hovanessian A.G. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 1990, 62:379.
25. Molle C., Nguyen M., Flamand V., Renneson J., Trottein F., De Wit D., Willems F., Goldman M., Goriely S. IL-27 synthesis induced by TLR ligation critically depends on IFN regulatory factor 3. J. Immunol. 2007, 178:7607.
26. Novoa R., Bacellar O., Nascimento M., Cardoso T.M., Ramasawmy R., Oliveira W.N., Schriefer A., Carvalho E.M. IL-17 and regulatory cytokines (IL-10 and IL-27) in L. braziliensis infection. Parasite Immunol. 2011, 33:132.
27. Pereira R.M., Teixeira K.L., Barreto-de-Souza V., Calegari-Silva T.C., De-Melo L.D., Soares D.C., Bou-Habib D.C., Silva A.M., Saraiva E.M., Lopes U.G. Novel role for the double-stranded RNA-activated protein kinase PKR: modulation of macrophage infection by the protozoan parasite Leishmania. FASEB J. 2010, 24:617.
28. Pflanz S., Timans J.C., Cheung J., Rosales R., Kanzler H., Gilbert J., Hibbert L., Churakova T., Travis M., Vaisberg E., Blumenschein W.M., Mattson J.D., Wagner J.L., To W., Zurawski S., McClanahan T.K., Gorman D.M., Bazan J.F., de Waal Malefyt R., Rennick D., Kastelein R.A. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. Immunity 2002, 16:779.
29. Raven J.F., Koromilas A.E. PERK and PKR: old kinases learn new tricks. Cell Cycle 2008, 7:1146.
30. Rinchai D., Khaenam P., Kewcharoenwong C., Buddhisa S., Pankla R., Chaussabel D., Bancroft G.J., Lertmemongkolchai G. Production of interleukin-27 by human neutrophils regulates their function during bacterial infection. Eur. J. Immunol. 2012, 42:3280.
31. Sacks D., Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2002, 2:845.
32. Sadler A.J., Williams B.R. Structure and function of the protein kinase R. Curr. Top. Microbiol. Immunol. 2007, 316:253.
33. Silva A.M., Whitmore M., Xu Z., Jiang Z., Li X., Williams B.R. Protein kinase R (PKR) interacts with and activates mitogen-activated protein kinase kinase 6 (MKK6) in response to double-stranded RNA stimulation. J. Biol. Chem. 2004, 279:37670.
34. Sun J., Dodd H., Moser E.K., Sharma R., Braciale T.J. CD4+ T cell help and innate-derived IL-27 induce Blimp-1-dependent IL-10 production by antiviral CTLs. Nat. Immunol. 2011, 12:327.
35. Vivarini A.deC., Pereira R.deM., Teixeira K.L., Calegari-Silva T.C., Bellio M., Laurenti M.D., Corbett C.E., Gomes C.M., Soares R.P., Silva A.M., Silveira F.T., Lopes U.G. Human cutaneous leishmaniasis: interferon-dependent expression of double-stranded RNA-dependent protein kinase (PKR) via TLR2. FASEB J. 2011, 25:4162.
36. Wang H., Meng R., Li Z., Yang B., Liu Y., Huang F., Zhang J., Chen H., Wu C. IL-27 induces the differentiation of Tr1-like cells from human naive CD4+ T cells via the phosphorylation of STAT1 and STAT3. Immunol. Lett. 2011, 136:21.
37. Wirtz S., Becker C., Fantini M.C., Nieuwenhuis E.E., Tubbe I., Galle P.R., Schild H.J., Birkenbach M., Blumberg R.S., Neurath M.F. EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-kappa B activation. J. Immunol. 2005, 174:2814.
38. World Health Organization World Health Organization Working to Overcome the Global Impact of Neglected Tropical Disease. First WHO Report on Neglected Disease 2010, World Health Organization, Geneva. Switzerland.
39. Yoshida H., Miyazaki Y. Regulation of immune responses by interleukin-27. Immunol. Rev. 2008, 226:234.
40. Yoshida H., Hamano S., Senaldi G., Covey T., Faggioni R., Mu S., Xia M., Wakeham A.C., Nishina H., Potter J., Saris C.J., Mak T.W. WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 2001, 15:569.
41. Yoshida H., Nakaya M., Miyazaki Y. Interleukin 27: a double-edged sword for offense and defense. J. Leukoc. Biol. 2009, 86:1295.